Atenolol (Page 6 of 6)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 25 mg (1000 Tablet Bottle)

NDC 13107-168-99

Atenolol Tablets, USP

25 mg

Rx only 1000 Tablets

Aurobinod

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 25 mg (1000 Tablet Bottle)
(click image for full-size original)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 50 mg (1000 Tablet Bottle)

NDC 13107-169-99

Atenolol Tablets, USP

50 mg

Rx only 1000 Tablets

Aurobinod

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 50 mg (1000 Tablet Bottle)
(click image for full-size original)

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL — 100 mg (1000 Tablet Bottle)

NDC 13107-170-99

Atenolol Tablets, USP

100 mg

Rx only 1000 Tablets

Aurobinod

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL -- 100 mg (1000 Tablet Bottle)
(click image for full-size original)
ATENOLOL atenolol tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:13107-168
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ATENOLOL (ATENOLOL) ATENOLOL 25 mg
Inactive Ingredients
Ingredient Name Strength
SODIUM STARCH GLYCOLATE TYPE A POTATO
CROSPOVIDONE
POVIDONE K90
CELLULOSE, MICROCRYSTALLINE
SILICON DIOXIDE
MAGNESIUM STEARATE
Product Characteristics
Color WHITE (White to Off-white) Score no score
Shape ROUND (Flat-face, Beveled-edge) Size 6mm
Flavor Imprint Code D;21
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:13107-168-01 100 TABLET (100 TABLET) in 1 BOTTLE None
2 NDC:13107-168-99 1000 TABLET (1000 TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078512 06/20/2011
ATENOLOL atenolol tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:13107-169
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ATENOLOL (ATENOLOL) ATENOLOL 50 mg
Inactive Ingredients
Ingredient Name Strength
SODIUM STARCH GLYCOLATE TYPE A POTATO
CROSPOVIDONE
POVIDONE K90
CELLULOSE, MICROCRYSTALLINE
SILICON DIOXIDE
MAGNESIUM STEARATE
Product Characteristics
Color WHITE (White to Off-white) Score 2 pieces
Shape ROUND (Flat-face, Beveled-edge) Size 7mm
Flavor Imprint Code D;22
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:13107-169-01 100 TABLET (100 TABLET) in 1 BOTTLE None
2 NDC:13107-169-99 1000 TABLET (1000 TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078512 06/20/2011
ATENOLOL atenolol tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:13107-170
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ATENOLOL (ATENOLOL) ATENOLOL 100 mg
Inactive Ingredients
Ingredient Name Strength
SODIUM STARCH GLYCOLATE TYPE A POTATO
CROSPOVIDONE
POVIDONE K90
CELLULOSE, MICROCRYSTALLINE
SILICON DIOXIDE
MAGNESIUM STEARATE
Product Characteristics
Color WHITE (White to Off-white) Score no score
Shape ROUND (Flat-face, Beveled-edge) Size 9mm
Flavor Imprint Code D;23
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:13107-170-01 100 TABLET (100 TABLET) in 1 BOTTLE None
2 NDC:13107-170-99 1000 TABLET (1000 TABLET) in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078512 06/20/2011
Labeler — Aurolife Pharma LLC (829084461)

Revised: 07/2011 Aurolife Pharma LLC

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.